Clinical trial / 2018
Calorie restriction improved cardiometabolic risk markers in healthy nonobese adults over two years
In an ancillary randomized controlled trial of 53 healthy nonobese adults, 24 months of caloric restriction decreased body weight by 9 ± 0.5 kg, visceral adipose tissue by 0.5 ± 0.01 kg, and blood pressure (systolic -8 ± 3 mmHg; diastolic -6 ± 2 mmHg) compared to ad libitum eating. Total cholesterol fell by 13.6 ± 5.3 mg/dl, LDL-cholesterol decreased by 12.9 ± 4.4 mg/dl, and estimated 10-year cardiovascular risk dropped by 30%. Insulin resistance initially improved during weight loss, but this change was not maintained during weight maintenance.
- Study type
- Randomized controlled trial
- Who was studied
- 53 healthy nonobese adults (17 men, 36 women)
- What was measured
- Cardiometabolic risk factors, adipose tissue, lipid profile, and insulin resistance
THE PAPER
Significant improvement in cardiometabolic health in healthy nonobese individuals during caloric restriction-induced weight loss and weight loss maintenance.
Most J, Gilmore LA, Smith SR, Han H, Ravussin E, Redman LM. Am J Physiol Endocrinol Metab, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.